Intrinsic subtype-associated changes in the plasma proteome in breast cancer

Harikrishna Nakshatri, Guihong Qi, Jinsam You, Bemis Kerry, Bryan Schneider, Robin Zon, Charles Buck, Fred Regnier, Mu Wang

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Breast cancers are classified into five intrinsic subtypes: Luminal subtype A, Luminal subtype B, HER2+, Basal, and Normal-like. In this study, we compared the plasma proteome of patients with Luminal A, Luminal B, HER2+, and Basal subtype with plasma from healthy individuals. Protein changes were considered significant if q-value (false discovery rate) was less than 5%. The highest number of changes in the plasma proteome was observed in patients with Luminal type B followed by Basal type breast cancers. The plasma proteome of Luminal A and HER21 breast cancer patients did not differ significantly from healthy individuals. In Basal breast cancer, a significant number of plasma proteins were downregulated compared with healthy individuals. Acute phase-response proteins α-glycoprotein orosomucoid 1 and serum amyloid protein P were specifically upregulated in the plasma of Luminal B breast cancer patients, suggesting prevalence of low-grade inflammation. Proteins involved in immune response and free radical scavenging were downregulated in the plasma of Luminal B patients, which is in agreement with defective immune system observed in cancer patients. These results reveal intrinsic subtype specific changes in the plasma proteome that may influence tumor progression as well as the systemic effects of cancer.

Original languageEnglish
Pages (from-to)1305-1313
Number of pages9
JournalProteomics - Clinical Applications
Volume3
Issue number11
DOIs
StatePublished - Dec 2009

Fingerprint

Proteome
Breast Neoplasms
Plasmas
Blood Proteins
Down-Regulation
Amyloidogenic Proteins
Orosomucoid
Neoplasms
Acute-Phase Reaction
Proteins
Acute-Phase Proteins
Immune system
Scavenging
Free Radicals
Tumors
Immune System
Glycoproteins
Inflammation

Keywords

  • Breast cancer
  • Intrinsic subtypes
  • Plasma

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Intrinsic subtype-associated changes in the plasma proteome in breast cancer. / Nakshatri, Harikrishna; Qi, Guihong; You, Jinsam; Kerry, Bemis; Schneider, Bryan; Zon, Robin; Buck, Charles; Regnier, Fred; Wang, Mu.

In: Proteomics - Clinical Applications, Vol. 3, No. 11, 12.2009, p. 1305-1313.

Research output: Contribution to journalArticle

Nakshatri, Harikrishna ; Qi, Guihong ; You, Jinsam ; Kerry, Bemis ; Schneider, Bryan ; Zon, Robin ; Buck, Charles ; Regnier, Fred ; Wang, Mu. / Intrinsic subtype-associated changes in the plasma proteome in breast cancer. In: Proteomics - Clinical Applications. 2009 ; Vol. 3, No. 11. pp. 1305-1313.
@article{55c3709abfbb44eea6fff55c1f94c9e4,
title = "Intrinsic subtype-associated changes in the plasma proteome in breast cancer",
abstract = "Breast cancers are classified into five intrinsic subtypes: Luminal subtype A, Luminal subtype B, HER2+, Basal, and Normal-like. In this study, we compared the plasma proteome of patients with Luminal A, Luminal B, HER2+, and Basal subtype with plasma from healthy individuals. Protein changes were considered significant if q-value (false discovery rate) was less than 5{\%}. The highest number of changes in the plasma proteome was observed in patients with Luminal type B followed by Basal type breast cancers. The plasma proteome of Luminal A and HER21 breast cancer patients did not differ significantly from healthy individuals. In Basal breast cancer, a significant number of plasma proteins were downregulated compared with healthy individuals. Acute phase-response proteins α-glycoprotein orosomucoid 1 and serum amyloid protein P were specifically upregulated in the plasma of Luminal B breast cancer patients, suggesting prevalence of low-grade inflammation. Proteins involved in immune response and free radical scavenging were downregulated in the plasma of Luminal B patients, which is in agreement with defective immune system observed in cancer patients. These results reveal intrinsic subtype specific changes in the plasma proteome that may influence tumor progression as well as the systemic effects of cancer.",
keywords = "Breast cancer, Intrinsic subtypes, Plasma",
author = "Harikrishna Nakshatri and Guihong Qi and Jinsam You and Bemis Kerry and Bryan Schneider and Robin Zon and Charles Buck and Fred Regnier and Mu Wang",
year = "2009",
month = "12",
doi = "10.1002/prca.200900040",
language = "English",
volume = "3",
pages = "1305--1313",
journal = "Proteomics - Clinical Applications",
issn = "1862-8346",
publisher = "Wiley-VCH Verlag",
number = "11",

}

TY - JOUR

T1 - Intrinsic subtype-associated changes in the plasma proteome in breast cancer

AU - Nakshatri, Harikrishna

AU - Qi, Guihong

AU - You, Jinsam

AU - Kerry, Bemis

AU - Schneider, Bryan

AU - Zon, Robin

AU - Buck, Charles

AU - Regnier, Fred

AU - Wang, Mu

PY - 2009/12

Y1 - 2009/12

N2 - Breast cancers are classified into five intrinsic subtypes: Luminal subtype A, Luminal subtype B, HER2+, Basal, and Normal-like. In this study, we compared the plasma proteome of patients with Luminal A, Luminal B, HER2+, and Basal subtype with plasma from healthy individuals. Protein changes were considered significant if q-value (false discovery rate) was less than 5%. The highest number of changes in the plasma proteome was observed in patients with Luminal type B followed by Basal type breast cancers. The plasma proteome of Luminal A and HER21 breast cancer patients did not differ significantly from healthy individuals. In Basal breast cancer, a significant number of plasma proteins were downregulated compared with healthy individuals. Acute phase-response proteins α-glycoprotein orosomucoid 1 and serum amyloid protein P were specifically upregulated in the plasma of Luminal B breast cancer patients, suggesting prevalence of low-grade inflammation. Proteins involved in immune response and free radical scavenging were downregulated in the plasma of Luminal B patients, which is in agreement with defective immune system observed in cancer patients. These results reveal intrinsic subtype specific changes in the plasma proteome that may influence tumor progression as well as the systemic effects of cancer.

AB - Breast cancers are classified into five intrinsic subtypes: Luminal subtype A, Luminal subtype B, HER2+, Basal, and Normal-like. In this study, we compared the plasma proteome of patients with Luminal A, Luminal B, HER2+, and Basal subtype with plasma from healthy individuals. Protein changes were considered significant if q-value (false discovery rate) was less than 5%. The highest number of changes in the plasma proteome was observed in patients with Luminal type B followed by Basal type breast cancers. The plasma proteome of Luminal A and HER21 breast cancer patients did not differ significantly from healthy individuals. In Basal breast cancer, a significant number of plasma proteins were downregulated compared with healthy individuals. Acute phase-response proteins α-glycoprotein orosomucoid 1 and serum amyloid protein P were specifically upregulated in the plasma of Luminal B breast cancer patients, suggesting prevalence of low-grade inflammation. Proteins involved in immune response and free radical scavenging were downregulated in the plasma of Luminal B patients, which is in agreement with defective immune system observed in cancer patients. These results reveal intrinsic subtype specific changes in the plasma proteome that may influence tumor progression as well as the systemic effects of cancer.

KW - Breast cancer

KW - Intrinsic subtypes

KW - Plasma

UR - http://www.scopus.com/inward/record.url?scp=77951046534&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951046534&partnerID=8YFLogxK

U2 - 10.1002/prca.200900040

DO - 10.1002/prca.200900040

M3 - Article

C2 - 21136952

AN - SCOPUS:77951046534

VL - 3

SP - 1305

EP - 1313

JO - Proteomics - Clinical Applications

JF - Proteomics - Clinical Applications

SN - 1862-8346

IS - 11

ER -